US Vitamin D Market Extends Decline as Early-June Weakness Deepens

US Vitamin D prices continued to show signs of softness in early June, extending the downward momentum that shaped trading conditions through May. Market participants reported that overall sentiment remained cautious, with Vitamin D demand steady but unspectacular and buyers reluctant to take on additional volumes amid stable production and minimal cost pressure. Despite a brief mid May uptick, the broader trend pointed to persistent weakness. Throughout May, Vitamin D activity was largely rangebound, supported by balanced supply–demand fundamentals and smooth logistics. However, thin liquidity in this specialty feedstock meant that even modest shifts in order flow had an outsized impact on market direction. This dynamic became more pronounced at the start of June, when a clear decline signaled a shift in momentum and reinforced the market’s vulnerability to sentiment driven moves. Analysts noted that the prolonged easing of moving average indicators underscores the sustained bearish tone. While no major supply disruptions or cost shocks are expected, the near term outlook for Vitamin D remains cautious. Renewed buying or inventory adjustments could stabilize conditions, but traders are closely watching weekly assessments to determine whether early June weakness marks the start of a deeper trend.